World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
120
Citations
83325
World Ranking
327
National Ranking
207

Medicine

D-Index
120
Citations
83348
World Ranking
3664
National Ranking
2021

Henry Masur publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Henry Masur sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 427 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Henry Masur D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Henry Masur sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 120 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Henry Masur is affiliated with the National Institutes of Health in the United States. Their research primarily spans the field of Medicine, with a significant focus on Epidemiology, Infectious Diseases, Hepatology, General Health Professions, and Critical Care and Intensive Care Medicine.

The scientist's work covers several important research topics including:

  • Hepatitis C virus research
  • HIV, Drug Use, Sexual Risk
  • HIV/AIDS Research and Interventions
  • Sepsis Diagnosis and Treatment
  • Opioid Use Disorder Treatment
  • HIV/AIDS drug development and treatment
  • Nosocomial Infections in ICU

Henry Masur is frequently published in the following venues:

  • Open Forum Infectious Diseases (12 publications)
  • Critical Care Medicine (8 publications)
  • Clinical Infectious Diseases (6 publications)
  • Annals of Internal Medicine (3 publications)
  • Journal of Hepatology (3 publications)

Recent papers authored or co-authored by Henry Masur include:

  • Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021), published in Intensive Care Medicine
  • Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021 (2021), published in Critical Care Medicine
  • Executive Summary: Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock 2021 (2021), published in Critical Care Medicine
  • Infectious Diseases Society of America Position Paper: Recommended Revisions to the National Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) Sepsis Quality Measure (2020), published in Clinical Infectious Diseases
  • Considerations for Empiric Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial Resistance (2020), published in The Journal of Infectious Diseases

Henry Masur collaborates often with the following co-authors:

  • Sarah Kattakuzhy (21 joint publications)
  • Elana Rosenthal (20 joint publications)
  • Shyam Kottilil (16 joint publications)
  • Amanda D. Castel (16 joint publications)
  • Anne K. Monroe (14 joint publications)

Best Publications

  • Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.

    Laura Evans;Andrew Rhodes;Waleed Alhazzani;Massimo Antonelli

  • Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

    R. Phillip Dellinger;Jean M. Carlet;Henry Masur;Herwig Gerlach

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents

    A. S. Fauci;J. G. Bartlett;E. P. Goosby;M. D. Smith

  • Guidelines for the Prevention of Intravascular Catheter-related Infections

    Naomi P. O'Grady;Mary Alexander;Lillian A. Burns;E. Patchen Dellinger

  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

    J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach

  • Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention.

    Naomi P. O'Grady;Mary Alexander;E. Patchen Dellinger;Julie L. Gerberding

  • An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction.

    Henry Masur;Mary Ann Michelis;Jeffrey B. Greene;Ida Onorato

  • Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.

    H C Lane;H Masur;L C Edgar;G Whalen

  • Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.

    Jonathan E. Kaplan;Constance Benson;King K. Holmes;John T. Brooks

  • Acquired Immunodeficiency Syndrome: Epidemiologic, Clinical, Immunologic, and Therapeutic Considerations

    A S Fauci;A M Macher;D L Longo;H C Lane

  • Guidelines for the prevention of intravascular catheter-related infections.

    Naomi P. O'Grady;Mary Alexander;E. Patchen Dellinger;Julie L. Gerberding

  • Pneumocystis carinii Pneumonia: A Comparison Between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other Immunodeficiencies

    Joseph A. Kovacs;John W. Hiemenz;Abe M. Macher;Diane Stover

  • HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

    Richard T. Davey;Niranjan Bhat;Christian Yoder;Tae Wook Chun

  • Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the Fungi

    Jeffrey C. Edman;Joseph A. Kovacs;Henry Masur;Daniel V. Santi

  • Guidelines for the Prevention of Intravascular Catheter-Related Infections

    Naomi P. O'Grady;Mary Alexander;E. Patchen Dellinger;Julie L. Gerberding

  • Cryptococcosis in the acquired immunodeficiency syndrome.

    Joseph A. Kovacs;Andrea A. Kovacs;Michael Polis;W. Craig Wright

  • Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America.

    Naomi P. O'Grady;Philip S. Barie;John G. Bartlett;Thomas Bleck

  • CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection.

    H Masur;F P Ognibene;R Yarchoan;J H Shelhamer

  • Guidelines for preventing opportunistic infections among HIV-infected persons - 2002

    Henry Masur;Jonathan E. Kaplan;King K. Holmes;Beverly Alston

Frequent Co-Authors

Joseph A. Kovacs
Joseph A. Kovacs National Institutes of Health
Michael A. Polis
Michael A. Polis National Institute of Allergy and Infectious Diseases
Shyam Kottilil
Shyam Kottilil University of Maryland, Baltimore
H. Clifford Lane
H. Clifford Lane National Institute of Allergy and Infectious Diseases
Anthony S. Fauci
Anthony S. Fauci Georgetown University
Richard T. Davey
Richard T. Davey National Institute of Allergy and Infectious Diseases
James H. Shelhamer
James H. Shelhamer National Institutes of Health
Julia A. Metcalf
Julia A. Metcalf National Institute of Allergy and Infectious Diseases
Joseph E. Parrillo
Joseph E. Parrillo Hackensack University Medical Center
Vee J. Gill
Vee J. Gill National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens multiple career avenues, especially in healthcare and research. For professionals aiming to enhance their qualifications, exploring online nursing programs offers flexible options. Those without a nursing background can consider online nursing programs for non nurses, which provide foundational knowledge and a pathway into nursing practice.

Nurses interested in advancing their clinical practice may look into accelerated np programs online. These programs help experienced nurses earn their Nurse Practitioner credentials more quickly while balancing work commitments.

For those focused on acute and specialized care, acnp programs provide targeted training to transition from Family Nurse Practitioner roles to Acute Care Nurse Practitioner positions, a critical step for working in more intensive environments.

Understanding potential earnings is equally important. The doctor of nursing practice salary varies by state, reflecting differences in demand, cost of living, and healthcare infrastructure. This data helps prospective students make informed decisions about where to study and practice after graduation.

Best Scientists Citing Henry Masur

Trending Scientists

Recently Published Articles